Cagent Vascular reported raising $41 Million in an initial SEC Form D filing, from an offering of $41 Million
Round Type
Series D
WayneHealthcareHealth CareInvestors
Description
Cagent Vascular, Inc. has announced the successful first human use of its Serranator® SONIC Intravascular Lithotripsy (IVL) System and has closed a $41 million Series D financing round. The funds will support the clinical advancement and commercialization of the company's dual-modality IVL platform. This funding marks a significant milestone in Cagent's development of its innovative IVL technologies
Who to call at Cagent Vascular, and when
A new round usually means Cagent Vascular is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cagent Vascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cagent Vascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cagent Vascular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cagent Vascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cagent Vascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.